Filing Details
- Accession Number:
- 0001628280-23-030224
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-22 16:09:35
- Reporting Period:
- 2023-08-18
- Accepted Time:
- 2023-08-22 16:09:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501697 | X4 Pharmaceuticals Inc | XFOR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1201256 | S Michael Wyzga | C/O X4 Pharmaceuticals, Inc. 61 North Beacon Street, 4Th Floor Boston MA 02134 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-08-18 | 25,000 | $1.20 | 76,667 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at $1.195 and $1.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price set forth in this footnote.
- Of the shares of common stock reported, 48,333 shares represent restricted stock units.
Billionaire Hedge Funds
